USFDA conducts pre-approval inspection at Lupin’s Pune Biotech facility

20 Sep 2025 Evaluate

U.S. Food and Drug Administration (USFDA) has conducted a product-specific Pre-Approval Inspection at Lupin’s Pune Biotech facility. The inspection has been conducted from September 08 to September 19, 2025. The inspection closed with four observations.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×